Testing a new imaging system during heart ablation
Part of Heart & circulation clinical trials.
This study tests a new imaging system (CHORUS IDx) that uses 2D ultrasound pictures to help doctors during a heart ablation procedure. It may help guide the procedure more safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a heart procedure (ablation) to treat an abnormal heart rhythm using a Boston Scientific system.
- You do not have any artificial heart valves or devices that close a hole in the heart.
- You do not have poor vein access, an active infection, or a blood clot in the heart.
- You are not pregnant or breastfeeding.
- You are not currently enrolled in another research study that would conflict with this one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging system (VERAFEYE) that helps doctors guide catheter ablation, a procedure to fix irregular heartbeats like atrial fibrillation. It aims to see if the system makes the procedure safer or more effective.
This study tests a new imaging catheter (VERAFEYE) to help doctors guide ablation procedures for atrial flutter or atrial fibrillation. It may lead to safer, more precise treatment of these heart rhythm problems.
This study compares two different ablation procedures (treatments that target heart rhythm triggers) for people with atrial fibrillation and reduced heart pumping. It aims to see which approach works best and is safest for improving your heart rhythm when you also have heart failure.
This study tests a new imaging technique to help guide heart ablation procedures for certain heart rhythm problems. It may help doctors see exactly where to treat.
This trial tests a new heart-mapping technique to help doctors treat a fast heart rhythm caused by heart disease. It might improve the precision of the procedure, making it safer and more effective for patients with this condition.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
Hear when a new Atrial Arrhythmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.